Comparison

Rivoglitazone HCl European Partner

Item no. TMO-T28542-100mg
Manufacturer TargetMol
CASRN 299176-11-7
Amount 100 mg
Quantity options 100 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles Cl.O=C1SC(C(=O)N1)CC2=CC=C(OCC3=NC=4C=CC(OC)=CC4N3C)C=C2
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias CI 1037,CS011,CS-011,CI-1037,CI1037
Shipping Condition Cool pack
Available
Shipping Temperature
Cool pack
Storage Conditions
-20°
Molecular Weight
433, 91
Description
Rivoglitazone, also known as CI-1037; CS-011; DE-101; R-119702; Rivo, is a peroxisome proliferator-activated receptor γ agonist (PARPγ agonist) potentially for the treatment of type 2 diabetes. Rivoglitazone has been shown, through small clinical studies, to decrease hemoglobin A(1c) (A1C) by 0.11-1.1% when compared with placebo and may provide greater A1C reduction than pioglitazone. Rivoglitazone reduces hyperglycemia, hyperinsulinemia, and hypertriglyceridemia by acting as an agonist of PPAR-γ. Rivoglitazone is the most potent PPAR-γ agonist.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close